UConn Health has formed a new clinical collaboration with Duke University to bring advanced brain tumor care to Connecticut patients.

In an effort to gain access to Duke’s world renowned Preston Robert Tisch Brain Tumor Center, the UConn Health Division of Neurosurgery is collaborating with Duke’s PRTBTC for the co-management of UConn Health’s brain tumor patients.

This important relationship will provide UConn Health brain tumor patients access to very specialized brain tumor treatments available at Duke. UConn Health and Duke envision brain tumor services to be provided by Dr. Ketan R. Bulsara’s neurosurgery team at UConn Health with evaluation for additional treatments by Dr. Henry S. Friedman’s team at Duke’s Preston Robert Tisch Brain Tumor Center.

“Consistent with the personalized care goals of UConn Health, the collaboration with The Preston Robert Tisch Brain Tumor Center at Duke will provide the residents of Connecticut and beyond access to novel and potentially lifesaving clinical treatments in collaboration with the premier brain tumor center in the world,” said Dr. Ketan R. Bulsara, UConn Health’s chief of neurosurgery.

“This collaboration will allow patients with brain tumors who receive initial intervention at UConn to derive the benefit of the cutting edge therapy available at The Preston Robert Tisch Brain Tumor Center at Duke,” said Dr. Henry S. Friedman, professor of neurosurgery at Duke University School of Medicine and a member of the Duke Cancer Institute.

“When it comes to patient care, especially the challenging treatment of brain tumors, medicine and science should know no boundaries or borders,” said Dr. Andy Agwunobi, CEO of UConn Health and UConn John Dempsey Hospital. “Excellence always finds excellence. I am pleased to see Dr. Ketan Bulsara and our skilled neurosurgery team going the extra miles to bring nothing but the best to Connecticut’s patients.”

To learn more about the Division of Neurosurgery at UConn Health, visit: https://health.uconn.edu/neurosurgery/.